Brand new UK startup RQ Biotechnology has been thrust into the spotlight after signing a $157 million licensing The post AstraZeneca buys into startup...
Health data research in the UK is rapidly evolving, with new capabilities emerging through the rise of hybrid The post Unlocking the potential of healthcare...
Enzolytics Inc (OTCMKTS: ENZC) is making a powerful move up the charts in recent days since reversing off $0.06 support levels, the second time it has...
Considerable scientific progress across neurological diseases and disorders was reported at the recent 74th American Academy of Neurology The post Recent...
Biomarkers are components that may be present in biological samples and are related to specific diseases. Therefore, doctors can analyze biological samples...
By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT Business Update FORTRESS Trial Fully Enrolled; Topline Results in September 2022 On...
PITTSBURGH, May 17, 2022 – Unlike other infectious diseases that affect the lungs, the immune response to fight tuberculosis (TB) infections develops...
Are Putin And Xi 'Gray Champions'? Part 1 Authored by Jim Quinn via The Burning Platform blog, “Long, long may it be, ere he comes again!...
Monday woes were shared by Bristol Myers Squibb and Synairgen, as their clinical trial candidates failed to perform as expected.
Eli Lilly scored another win against diabetes Friday as the company’s once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like...
Synthetic Biology: The $3.6 Trillion Science Changing Life As We Know It Synthetic biology (synbio) is a field of science that redesigns organisms...
Up to 20% of US children have an anxiety disorder, and many suffer in silence.
(MEMPHIS, Tenn. – May 12, 2022) Interim results of an ongoing clinical trial found lentiviral gene therapy is safe and effective for treatment of infants...
SAN FRANCISCO, CA—May 12, 2022—Viruses in the herpesvirus family are leading causes of birth defects, blindness, and failed organ transplants worldwide....
• In an international collaboration, researchers led by Nuria Montserrat, ICREA Research Professor at IBEC, have generated human mini-kidneys that simulate...
Inovio Pharmaceuticals announced a leadership change at the helm and the discontinuation of a Phase III COVID-19 vaccine study.
Global life sciences company Cytiva hasn’t been shy about its plans to pump money into expanding global operations. Tuesday, it announced that it would...
The Institute for Clinical and Economic Review, a pharma drug pricing watchdog, recently dug into the data on three Covid-19 therapeutics, voting 11-2...
Not content with a $1.2 billion licensing deal for Biohaven Pharma’s oral migraine therapy rimegepant, Pfizer has just The post Pfizer upgrades Biohaven...
BioNTech continues to build on the success of the company's mRNA COVID-19 vaccine co-developed with Pfizer, rapidly expanding its investigational pipeline...
The electronics retailer announced plans to expand its health, outdoor living and transportation offering.
The Psychology Of Manipulation: 6 Lessons From The Master Of Propaganda Authored by Ryan Matters via Off-Guardian.org, Edward L. Bernays...
If you can envision a solution that solves a customer's problem, it helps to have technical skills if you want to bring it to market. But...
The Golden Age for Life Sciences Innovation The post PING Conference 2022 – The Golden Age for Life Sciences Innovation appeared first on .
A sudden uptick in demand for HRT may be one reason behind the sudden shortages.
A sudden uptick in demand for HRT may be one reason behind the sudden shortages.
A sudden uptick in demand for HRT may be one reason behind the sudden shortages.
Penny stocks with huge potential according to analysts in 2022. The post Penny Stocks With Huge Potential According To 4 Wall Street Analysts appeared...
Hot penny stocks under $1 to watch this week. The post Hot Penny Stocks To Buy For Under $1 This Week appeared first on Penny Stocks...
"What a year this is shaping up to be!” say leaders at AbelsonTaylor. “After last year’s amazing growth, we are still growing at a very healthy...